RECRUITINGOBSERVATIONAL

Nutrition and Clinical Outcomes in IBD

Nutrition and Body Composition and Association With Clinical Outcomes in Inflammatory Bowel Disease

About This Trial

The goal of this observational study is to demonstrate that nutritional status and body composition have an impact on clinical outcomes in inflammatory bowel disease (IBD). The main objectives are: 1. To compare the detection rates of undernutrition between a range of nutritional screening tools, physiological measures and assessment tools amongst patients with different IBD phenotypes 2. To correlate nutritional status, nutritional biomarkers and body composition with clinical outcomes in patients with IBD treated with advanced medical therapy or surgery 3. To determine a potential relationship between radiological muscle mass measurements and clinical outcomes in patients with IBD treated with advanced medical therapy or surgery Participants will undergo an assessment at pre-treatment baseline and then again at their scheduled follow-up. This is a non-interventional study and participants will not be required to have any invasive tests or hospital visits beyond that of standard clinical care.

Who May Be Eligible (Plain English)

Who May Qualify: - Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis or IBD-U) starting a new advanced medical therapy - Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis or IBD-U) undergoing an IBD-related surgery - Age \>16 - Patients able and willing to provide written willing to sign a consent form Who Should NOT Join This Trial: - Patients below the age of 16 - Patients who cannot provide willing to sign a consent form - Patients with a cardiac pacemaker or internal defibrillator - Patients with active cancer and other disorders associated with severe cachexia Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis or IBD-U) starting a new advanced medical therapy * Patients with inflammatory bowel disease (Crohn's disease, ulcerative colitis or IBD-U) undergoing an IBD-related surgery * Age \>16 * Patients able and willing to provide written informed consent Exclusion Criteria: * Patients below the age of 16 * Patients who cannot provide informed consent * Patients with a cardiac pacemaker or internal defibrillator * Patients with active cancer and other disorders associated with severe cachexia

Locations (1)

Barts Health NHS Trust

London, United Kingdom